ZVRA Latest Headlines

Top profitable small caps trading at bargain P/E multiples during Q2 earnings

at seekingalpha.com (Mon, 27-Jul 9:09 AM)

Canaccord Genuity Remains a Buy on Zevra Therapeutics (ZVRA)

at www.tipranks.com (Mon, 27-Jul 6:56 AM)

Zevra Therapeutics to Request Re-examination After Negative EMA Ruling on Arimoclomol for Niemann-Pick Disease Type C

Market Chameleon (Fri, 24-Jul 7:50 AM)

Analysts’ Top Healthcare Picks: NewAmsterdam Pharma Company (NAMS), Zevra Therapeutics (ZVRA)

at www.tipranks.com (Fri, 24-Jul 1:20 PM)

Analysts Offer Insights on Healthcare Companies: Zevra Therapeutics (ZVRA), Roche Holding AG (OtherRHHVF) and Quest Diagnostics (DGX)

at www.tipranks.com (Fri, 24-Jul 9:40 AM)

Zevra plunges on EU snub for rare disease therapy

at seekingalpha.com (Fri, 24-Jul 8:25 AM)

Zevra Transitions Chief Medical Officer Amid Strong Pipeline Progress and Upcoming Regulatory Milestones

Market Chameleon (Fri, 12-Jun 11:20 AM)

Zevra Secures Extended Patent Protection for MIPLYFFA, Solidifying Market Exclusivity to 2041

Market Chameleon (Tue, 9-Jun 10:32 AM)

Zevra’s MIPLYFFA Patent Listing Extends Protection to 2041—What This Means for Long-Term Exclusivity

Market Chameleon (Mon, 8-Jun 9:26 AM)